FGA (fibrinogen alpha chain)43 and FGB (fibrinogen beta chain)44 levels are correlated with disease severity in patients with cardiovascular disease, but these genes might provide new targets for the development of drugs to treat T1DM. Here, FGA is linked to cardiovascular disorder.